Literature DB >> 21765980

Ikaros isoforms: The saga continues.

Zhanjun Li1, Laura A Perez-Casellas, Aleksandar Savic, Chunhua Song, Sinisa Dovat.   

Abstract

Through alternate splicing, the Ikaros gene produces multiple proteins. Ikaros is essential for normal hematopoiesis and possesses tumor suppressor activity. Ikaros isoforms interact to form dimers and potentially multimeric complexes. Diverse Ikaros complexes produced by the presence of different Ikaros isoforms are hypothesized to confer distinct functions. Small dominant-negative Ikaros isoforms have been shown to inhibit the tumor suppressor activity of full-length Ikaros. Here, we describe how Ikaros activity is regulated by the coordinated expression of the largest Ikaros isoforms IK-1 and IK-H. Although IK-1 is described as full-length Ikaros, IK-H is the longest Ikaros isoform. IK-H, which includes residues coded by exon 3B (60 bp that lie between exons 3 and 4), is abundant in human but not murine hematopoietic cells. Specific residues that lie within the 20 amino acids encoded by exon 3B give IK-H DNA-binding characteristics that are distinct from those of IK-1. Moreover, IK-H can potentiate or inhibit the ability of IK-1 to bind DNA. IK-H binds to the regulatory regions of genes that are upregulated by Ikaros, but not genes that are repressed by Ikaros. Although IK-1 localizes to pericentromeric heterochromatin, IK-H can be found in both pericentromeric and non-pericentromeric locations. Anti-silencing activity of gamma satellite DNA has been shown to depend on the binding of IK-H, but not other Ikaros isoforms. The unique features of IK-H, its influence on Ikaros activity, and the lack of IK-H expression in mice suggest that Ikaros function in humans may be more complex and possibly distinct from that in mice.

Entities:  

Keywords:  Chromatin, Pericentromeric; IK-H; Ikaros; Leukemia; Transcription; γ satellite

Year:  2011        PMID: 21765980      PMCID: PMC3135861          DOI: 10.4331/wjbc.v2.i6.140

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  34 in total

1.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Unconventional potentiation of gene expression by Ikaros.

Authors:  Joseph Koipally; Elizabeth J Heller; John R Seavitt; Katia Georgopoulos
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

3.  Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.

Authors:  S Ghanshani; H Wulff; M J Miller; H Rohm; A Neben; G A Gutman; M D Cahalan; K G Chandy
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

4.  Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.

Authors:  B S Cobb; S Morales-Alcelay; G Kleiger; K E Brown; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

5.  Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros.

Authors:  Glenn Dorsam; Edward J Goetzl
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

6.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.

Authors:  L Sun; N Heerema; L Crotty; X Wu; C Navara; A Vassilev; M Sensel; G H Reaman; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

7.  Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator.

Authors:  L A Trinh; R Ferrini; B S Cobb; A S Weinmann; K Hahm; P Ernst; I P Garraway; M Merkenschlager; S T Smale
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

8.  Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis.

Authors:  K J Payne; J H Nicolas; J Y Zhu; L W Barsky; G M Crooks
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

9.  An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells.

Authors:  D W O'Neill; S S Schoetz; R A Lopez; M Castle; L Rabinowitz; E Shor; D Krawchuk; M G Goll; M Renz; H P Seelig; S Han; R H Seong; S D Park; T Agalioti; N Munshi; D Thanos; H Erdjument-Bromage; P Tempst; A Bank
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

10.  Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage.

Authors:  C Tonnelle; F Bardin; C Maroc; A M Imbert; F Campa; A Dalloul; C Schmitt; C Chabannon
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

View more
  14 in total

Review 1.  Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.

Authors:  Chandrika Gowda; Mario Soliman; Malika Kapadia; Yali Ding; Kimberly Payne; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2017-06-13

Review 2.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

3.  Ikaros in hematopoiesis and leukemia.

Authors:  Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

4.  Cell cycle-specific function of Ikaros in human leukemia.

Authors:  Zhanjun Li; Chunhua Song; Hongsheng Ouyang; Liangxue Lai; Kimberly J Payne; Sinisa Dovat
Journal:  Pediatr Blood Cancer       Date:  2011-11-21       Impact factor: 3.167

Review 5.  Ikaros and tumor suppression in acute lymphoblastic leukemia.

Authors:  Kimberly J Payne; Sinisa Dovat
Journal:  Crit Rev Oncog       Date:  2011

6.  High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma.

Authors:  Bufang Xu; Fengjie Liu; Yumei Gao; Jingru Sun; Yingyi Li; Yuchieh Lin; Xiangjun Liu; Yujie Wen; Shengguo Yi; Jingyang Dang; Ping Tu; Yang Wang
Journal:  Acta Derm Venereol       Date:  2021-12-07       Impact factor: 3.875

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  KU HAPLOINSUFFIENCY CAUSES A LYMPHOPROLIFERATIVE DISORDER OF IMMATURE T-CELL PRECURSORS DUE TO IKAROS MALFUNCTION.

Authors:  Zahide Ozer; Sanjive Qazi; Rita Ishkhanian; Paul Hasty; Hong Ma; Fatih M Uckun
Journal:  Int J Mol Med Sci       Date:  2013-06-21

Review 9.  Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.

Authors:  Kaitlin A Read; Devin M Jones; Aharon G Freud; Kenneth J Oestreich
Journal:  Immunol Rev       Date:  2020-12-17       Impact factor: 12.988

Review 10.  Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?

Authors:  Mamneet Manghera; Renée N Douville
Journal:  Retrovirology       Date:  2013-02-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.